Health Canada has granted a notice of compliance for Novartis Canada’s Kisqali (ribociclib tablets) plus an aromatase ...

Nicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...

The NSW government has announced an investment of A$20.7m ($13.39m) aimed at providing access to life-changing therapies.

The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a memorandum of understanding (MoU) to bolster vaccine ...

AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications ...

While the outlook for vaccines in the US looks bleak under Trump's administration, the UK is pressing ahead with securing its ...

Actio Biosciences has closed a Series B financing round, raising $66m for advancing the genetics-driven small molecule ...

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.

Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).

Tisento Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for zagociguat.

The test is currently available in private healthcare facilities but there are hopes it may be adopted by the NHS.

India has proposed increasing US manufacturing by Indian pharma providers of APIs and the final stages of drug processing ...